1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Dormancy is not necessary or sufficient for bacterial persistence.

      Antimicrobial Agents and Chemotherapy
      Anti-Bacterial Agents, pharmacology, Cell Division, Drug Resistance, Multiple, Bacterial, Escherichia coli, drug effects, growth & development, physiology, Flow Cytometry

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The antibiotic tolerances of bacterial persisters have been attributed to transient dormancy. While persisters have been observed to be growth inhibited prior to antibiotic exposure, we sought to determine whether such a trait was essential to the phenotype. Furthermore, we sought to provide direct experimental evidence of the persister metabolic state so as to determine whether the common assumption of metabolic inactivity was valid. Using fluorescence-activated cell sorting (FACS), a fluorescent indicator of cell division, a fluorescent measure of metabolic activity, and persistence assays, we found that bacteria that are rapidly growing prior to antibiotic exposure can give rise to persisters and that a lack of replication or low metabolic activity prior to antibiotic treatment simply increases the likelihood that a cell is a persister. Interestingly, a lack of significant growth or metabolic activity does not guarantee persistence, as the majority of even "dormant" subpopulations (>99%) were not persisters. These data suggest that persistence is far more complex than dormancy and point to additional characteristics needed to define the persister phenotype.

          Related collections

          Author and article information

          Journal
          23629720
          3697331
          10.1128/AAC.00243-13

          Chemistry
          Anti-Bacterial Agents,pharmacology,Cell Division,Drug Resistance, Multiple, Bacterial,Escherichia coli,drug effects,growth & development,physiology,Flow Cytometry

          Comments

          Comment on this article